Institutional investors juggle bitcoin ETF holdings, US filings show
FILE PHOTO: The seal of the U.S. Securities and Exchange Commission (SEC) is seen at their headquarters in Washington, D.C., U.S., May 12, 2021. Picture taken May 12, 2021. REUTERS/Andrew Kelly/ File Photo
(Reuters) -A number of high-profile asset managers cut their stakes in spot bitcoin exchange-traded funds amid a 12% drop in the cryptocurrency's price in the first quarter of 2025, according to recent regulatory filings.
This marks a shift from previous quarters when asset managers had typically increased their holdings in spot bitcoin ETFs, as shown in previous quarterly 13-F filings with the Securities and Exchange Commission.
Spot bitcoin ETFs, which made their market debut in January 2024, now paint a more complex picture. Hedge funds trimmed their holdings while some financial advisory firms and wealth funds boosted or rebalanced their positions.
"What we witnessed in the first quarter was the collapse of the premium that people were paying for bitcoin futures, which had set up a very lucrative basis trade," said Matt Hougan, chief investment officer of Bitwise Asset Manager.
Hedge funds seeking to profit from the spread between spot and futures prices could capture annualized yields in the region of 15%, Hougan said.
"But that premium collapsed and reached its nadir around the end of March," he said. "So I'm not surprised to see hedge funds trim their holdings."
Millennium Management LLC cut its holdings of iShares Bitcoin Trust ETF by 41% to 17.6 million shares and exited its position in the Invesco Galaxy Bitcoin ETF. It increased its stake in only two ETFs, boosting its holdings of the ARK 21 Shares Bitcoin ETF and the Grayscale Bitcoin Mini Trust.
Jersey-based Brevan Howard trimmed its stake in the iShares ETF by 15.6%.
The State of Wisconsin Investment Board, one of the earliest institutional investors to make a significant allocation to spot bitcoin ETFs in the first quarter of 2024, sold its entire six million share position in the iShares Bitcoin Trust in the first three months of this year.
Meanwhile, Brown University made its first foray into cryptocurrency ETF ownership during the same period, acquiring a stake in the same ETF, worth $4.9 million at the end of March.
Neither the state pension fund nor representatives from Brown University responded to requests for comment on their moves.
Abu Dhabi's Mubadala sovereign wealth fund added to its holdings of the iShares ETF in the first quarter, bringing its total position to 8,726,972 shares, valued at $408.5 million.
"What will be most important for me is whether, when all the data is finally in and we can analyze it, more investment advisory firms are stepping in," said Hougan.
"That wave of adoption may be a slow-moving train, but it has forward momentum."
(Reporting by Suzanne McGee; editing by Diane Craft)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
3 days ago
- The Star
Elon Musk gets more time to respond to US SEC lawsuit over Twitter stake
FILE PHOTO: Tesla CEO Elon Musk attends the Saudi-U.S. Investment Forum, in Riyadh, Saudi Arabia, May 13, 2025. REUTERS/Hamad I Mohammed/File Photo (Reuters) -The U.S. Securities and Exchange Commission has given Elon Musk six more weeks to respond to its civil lawsuit accusing the world's richest person of waiting too long in 2022 to reveal his large stake in Twitter, the social media company he later bought and renamed X. In a filing in federal court in Washington, D.C., the SEC and Musk agreed to push back the deadline for Musk's response to July 18 from June 6, calling it "reasonable and in the interest of conserving judicial resources." The SEC has said Musk's 11-day delay in disclosing his initial 5% Twitter stake let him to buy more than $500 million of the company's shares at artificially low prices, at the expense of unsuspecting investors. The agency's lawsuit seeks to force Musk to pay a civil fine and give up profits he didn't deserve. (Reporting by Jonathan Stempel in New York; Editing by Leslie Adler)
The Star
5 days ago
- The Star
US FDA launches AI tool to reduce time taken for scientific reviews
Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly (Reuters) -The U.S. Food and Drug Administration said on Monday that it had launched a generative AI tool, Elsa, aimed at improving efficiency across its operations, including scientific reviews. "Today's rollout of Elsa is ahead of schedule and under budget, thanks to the collaboration of our in-house experts across the centers," said FDA Commissioner Marty Makary. The agency said it is already using Elsa to expedite clinical protocol reviews, shorten the time needed for scientific evaluations, and pinpoint high-priority inspection targets. Once the FDA receives an application for a potential drug approval, it has six to 10 months to make a decision. Elsa assists with reading, writing, and summarizing tasks. It can summarize adverse events to support safety profile assessments of drugs and rapidly compare packaging inserts. "Elsa offers a secure platform for FDA employees to access internal documents while ensuring all information remains within the agency. The models do not train on data submitted by regulated industry, safeguarding the sensitive research and data handled by FDA staff," the FDA said. In May, the regulator said it would fully integrate AI by June 30, following an experimental run. (Reporting by Puyaan Singh in Bengaluru; Editing by Mohammed Safi Shamsi)
The Star
6 days ago
- The Star
Palantir defies tech gloom as Trump momentum powers stellar share gains
FILE PHOTO: A banner featuring the logo of Palantir Technologies (PLTR) is hung at the New York Stock Exchange (NYSE) on the day of their initial public offering (IPO) in Manhattan, New York City, U.S., September 30, 2020. REUTERS/Andrew Kelly/File Photo (Reuters) -Palantir Technologies has succeeded where most tech stocks have struggled this year: staying hot in a cooling market. The company's military-grade AI tools along with its deep defense ties and high-level government connections at a time when the U.S. is boosting spending on defense software have helped investors raise the bets on the stock. It has surged more than 70% this year and is the S&P 500's second-best performer - a standout in an otherwise sluggish tech market roiled by investor worries over U.S. tariffs and economic uncertainty. Palantir co-founder Peter Thiel was an early backer of President Donald Trump and has close ties with key Washington lawmakers, including Vice President JD Vance, whom he supported in a 2022 U.S. Senate race. "The relationships that Palantir's with senior members of the Trump administration are helpful for business," D.A. Davidson analyst Gil Luria said. Palantir in April won a $30 million contract from the U.S. Immigration and Customs Enforcement to develop an operating system that identifies undocumented immigrants and tracks self-deportations, its largest single award from the agency among 46 federal contract actions since 2011. "They probably benefit a little bit more with Trump because of the impetus on security, border and immigration," said Francisco Bido, senior portfolio manager at Palantir investor F/m Investments. "They're going to get a lot of work out of that." Palantir, however, downplayed the impact of political goodwill. "The politics around it change, so it gets increased visibility but we've been working with ICE since 2010," the company's communications head, Lisa Gordon, told Reuters. Founded in 2003 and listed in 2020, Palantir, which was initially backed by the CIA, has drawn investor interest in its growing AI platform that allows companies to simulate AI-related scenarios, debug code and test large language models. "No other large software company can currently combine that level of growth with high profitability and unique offering," Luria said. But its growth has largely been driven by U.S. government contracts which made up for more than 42% of its revenue in the March quarter. Sales to U.S. businesses accounted for 29%, while commercial sales outside the U.S. were down 5% from a year ago - a slide that some analysts point to Palantir's polarizing political profile and America-first stance. The rally in its stock builds on a 12-fold surge over the past two years that outpaced gains in red-hot companies such as Nvidia and brings with it a valuation premium. Palantir trades at a forward price-to-earnings ratio of 200.47, compared with Nvidia's 27.96. (Reporting by Arsheeya Bajwa in Bengaluru; Editing by Aditya Soni and Arun Koyyur)
